摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-butyl-2-(4-(5-(4-chlorophenyl)-4,4,5-trifluoro-4,5-dihydrothiazol-2-yl)phenoxy)acetamide

中文名称
——
中文别名
——
英文名称
N-butyl-2-(4-(5-(4-chlorophenyl)-4,4,5-trifluoro-4,5-dihydrothiazol-2-yl)phenoxy)acetamide
英文别名
N-butyl-2-[4-[5-(4-chlorophenyl)-4,4,5-trifluoro-1,3-thiazol-2-yl]phenoxy]acetamide
N-butyl-2-(4-(5-(4-chlorophenyl)-4,4,5-trifluoro-4,5-dihydrothiazol-2-yl)phenoxy)acetamide化学式
CAS
——
化学式
C21H20ClF3N2O2S
mdl
——
分子量
456.916
InChiKey
AQDFIPACSVKYKJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    30
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    76
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Fluorinated thiazoles for use in treating cancer
    申请人:Gil Santano Joan
    公开号:US08680126B2
    公开(公告)日:2014-03-25
    Compounds of formula (I) or their pharmaceutically acceptable salts, or their stereoisomers or mixtures of stereoisomers, where: R1 is selected from the group consisting of: phenyl, and phenyl mono-, di-, or tri-substituted by a radical independently selected from the group consisting of F, Cl, Br, I, (C1-C6)-alkyl, COO—(C1-C6)-alkyl, and (C1-C6)-alkoxy; and R2 is a radical selected from the same group as R1, further including a phenyl substituted in 4-position by a radical independently selected from the group consisting of —O(CH2)CONH(CH2)3CH3 and OCH2COOC(CH3)3, a biphenyl-4-yl, thiazol-2-yl, and a thiazol-2-yl mono- or di-substituted by a radical selected from F and phenyl; inhibit cell proliferation of tumor cells independently of p53 protein and may also induce apoptosis in several tumor cells independently of p53 protein, being useful for the treatment of several types of cancer.
    化合物的公式(I)或其药物可接受的盐,其立体异构体或立体异构体混合物,其中:R1选自以下组中的一种:苯基,以及独立于F,Cl,Br,I,(C1-C6)-烷基,COO-(C1-C6)-烷基和(C1-C6)-烷氧基的基团选择的苯基单,双或三取代基团; R2是从与R1相同的组中选择的基团,还包括在4位被独立于-O(CH2)CONH(CH2)3CH3和OCH2COOC(CH3)3的基团选择的苯基取代的苯基-4-基,噻唑-2-基,以及从F和苯基选择的噻唑-2-基单取代或双取代; 独立于p53蛋白质抑制肿瘤细胞增殖,也可以在几种独立于p53蛋白质的肿瘤细胞中诱导凋亡,适用于治疗多种癌症。
  • FLUORINATED THIAZOLES FOR USE IN TREATING CANCER
    申请人:Gil Santano Joan
    公开号:US20130190367A1
    公开(公告)日:2013-07-25
    Compounds of formula (I) or their pharmaceutically acceptable salts, or their stereoisomers or mixtures of stereoisomers, where: R 1 is selected from the group consisting of: phenyl, and phenyl mono-, di-, or tri-substituted by a radical independently selected from the group consisting of F, Cl, Br, I, (C 1 -C 6 )-alkyl, COO-(C 1 -C 6 )-alkyl, and (C 1 -C 6 )-alkoxy; and R 2 is a radical selected from the same group as R 1 , further including a phenyl substituted in 4-position by a radical independently selected from the group consisting of —O(CH 2 )CONH(CH 2 ) 3 CH 3 and OCH 2 COOC(CH 3 ) 3 , a biphenyl-4-yl, thiazol-2-yl, and a thiazol-2-yl mono- or di-substituted by a radical selected from F and phenyl; inhibit cell proliferation of tumor cells independently of p53 protein and may also induce apoptosis in several tumor cells independently of p53 protein, being useful for the treatment of several types of cancer.
    式(I)的化合物或其药学上可接受的盐,或其立体异构体或立体异构体混合物,其中:R1选自以下群组:苯基,以及苯基单、双、或三位上由以下基团中独立选择的基团取代:F、Cl、Br、I、(C1-C6)-烷基、COO-(C1-C6)-烷基和(C1-C6)-烷氧基;而R2是从与R1相同的群组中选择的基团,还包括在4位上由以下基团中独立选择的基团取代的苯基:—O(CH2)CONH(CH2)3CH3和OCH2COOC(CH3)3,联苯基-4-基、噻唑-2-基和噻唑-2-基单或双取代的基团中选择F和苯基的化合物,独立于p53蛋白质抑制肿瘤细胞增殖,也可能在几种独立于p53蛋白质的肿瘤细胞中诱导凋亡,可用于治疗多种类型的癌症。
  • US8680126B2
    申请人:——
    公开号:US8680126B2
    公开(公告)日:2014-03-25
  • A Trifluorinated Thiazoline Scaffold Leading to Pro-apoptotic Agents Targeting Prohibitins
    作者:Alba Pérez-Perarnau、Sara Preciado、Claudia Mariela Palmeri、Cristina Moncunill-Massaguer、Daniel Iglesias-Serret、Diana M. González-Gironès、Miriam Miguel、Satoki Karasawa、Satoshi Sakamoto、Ana M. Cosialls、Camila Rubio-Patiño、José Saura-Esteller、Rosario Ramón、Laia Caja、Isabel Fabregat、Gabriel Pons、Hiroshi Handa、Fernando Albericio、Joan Gil、Rodolfo Lavilla
    DOI:10.1002/anie.201405758
    日期:2014.9.15
    A new class of small molecules, with an unprecedented trifluorothiazoline scaffold, were synthesized and their pro‐apoptotic activity was evaluated. With an EC50 in the low micromolar range, these compounds proved to be potent inducers of apoptosis in a broad spectrum of tumor cell lines, regardless of the functional status of p53. Fast structure–activity relationship studies allowed the preparation
    合成了具有前所未有的三氟噻唑啉骨架的一类新的小分子,并评估了它们的促凋亡活性。EC 50处于低微摩尔范围内,无论p53的功能状态如何,这些化合物均被证明是在广泛的肿瘤细胞系中凋亡的有效诱导剂。快速的结构-活性关系研究允许制备最强的凋亡诱导候选物。使用高性能亲和纯化方法,我们确定了抑制素1和2,涉及维持细胞生存力的关键蛋白质,作为这些化合物的目标。
查看更多